PATENT CLAIM ANALYSIS

Application Number: 15757189
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "649000"]

Abstract:
The present disclosure provides a method of treating a patient with refractory or resistant cancer by administering a therapeutically effective amount of a compound of formula (I), such as Varlitinib, or an enantiomer thereof or a pharmaceutically acceptable salt of any one of the same. Also provided is a compound of formula (I) for use in the treatment of resistant or refractory cancer and use of a compound of formula (I) for the manufacture of a medicament for the treatment of resistant or refractory cancer.

Claim (Index 13):
A compound of formula (I) as defined in  claim 1 , for use in the manufacture of a medicament for the treatment of refractory or resistant cancer.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.93878
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15757133', '13641557', '12586849', '11470331', '14247799']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6578580037347707
- 35 USC 102 Novelty (BERT): 0.5155980228325069
- Combined Prediction Score: 0.6436320056445444
- Mean Citation Score: 167.225026
- Max Citation Score: 262.58035
- Similarity Product: 183.3900659031272

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test